Aptahem develops aptamer-based drugs for the treatment of acute life-threatening conditions
Aptahem has raised $1.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Aptahem is headquartered in Malmö, Sweden.
Aptahem develops aptamer-based drugs for the treatment of acute life-threatening conditions
Aptahem is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aptahem — Funding & Investors." VCBacked, April 24, 2026, https://www.vcbacked.co/company/aptahem. Accessed August 15, 2026.
VCBacked. (2026). Aptahem — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/aptahem
{{cite web |title=Aptahem — Funding & Investors |url=https://www.vcbacked.co/company/aptahem |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated